Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for Specified Drug Use-results Survey of Betanis Tablets (for Patients With Coexisting Cardiovascular Disease)

NCT02570035 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02570035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02570035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for Specified Drug Use-results Survey of Betanis Tablets (for Patients With Coexisting Cardiovascular Disease)
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
March 31, 2015
Enrollment
316 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, overactive bladder